{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P35354",
      "entity_text" : "Cox-2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0547" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Moreover, patients with moderate to high Cox-2 expression had a better tumor response to a Cox-2 inhibitor (celecoxib) in terms of a longer median survival period compared with those not receiving celecoxib [XREF_BIBR].",
  "reading_complete" : "2020-08-02T14:58:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:56:43Z",
  "trigger" : "expression",
  "evidence" : [ "Cox-2 expression" ],
  "pmc_id" : "4332968",
  "score" : 0
}